TRUOZA Trademark

Trademark Overview


On Thursday, October 12, 2017, a trademark application was filed for TRUOZA with the United States Patent and Trademark Office. The USPTO has given the TRUOZA trademark a serial number of 87643107. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, January 4, 2021. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The TRUOZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ...

General Information


Serial Number87643107
Word MarkTRUOZA
Filing DateThursday, October 12, 2017
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, January 4, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2018
Attorney NameNOT AVAILABLE
Law Office Location CodeM10
Employee NameVOHRA, SANJEEV KUMAR
CorrespondentTeva Pharmaceuticals USA, Inc.
400 Interpace Parkway
Parsippany NJ 07054

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 20, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address400 Interpace Parkway
Parsippany, NJ 07054

Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address1090 Horsham Road
North Wales, PA 19454

Trademark Events


Event DateEvent Description
Tuesday, January 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 4, 2021EXTENSION 5 GRANTED
Wednesday, December 16, 2020EXTENSION 5 FILED
Monday, January 4, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 16, 2020TEAS EXTENSION RECEIVED
Saturday, July 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2020EXTENSION 4 GRANTED
Thursday, July 2, 2020EXTENSION 4 FILED
Thursday, July 2, 2020TEAS EXTENSION RECEIVED
Thursday, January 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 7, 2020EXTENSION 3 GRANTED
Tuesday, January 7, 2020EXTENSION 3 FILED
Tuesday, January 7, 2020TEAS EXTENSION RECEIVED
Tuesday, July 2, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2019EXTENSION 2 GRANTED
Tuesday, July 2, 2019EXTENSION 2 FILED
Tuesday, July 2, 2019TEAS EXTENSION RECEIVED
Tuesday, January 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 4, 2019EXTENSION 1 GRANTED
Friday, January 4, 2019EXTENSION 1 FILED
Friday, January 4, 2019TEAS EXTENSION RECEIVED
Tuesday, July 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 30, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, May 7, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, May 4, 2018ASSIGNED TO PETITION STAFF
Wednesday, April 18, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 18, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, April 6, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 20, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 5, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 30, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 23, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 23, 2018NON-FINAL ACTION E-MAILED
Tuesday, January 23, 2018NON-FINAL ACTION WRITTEN
Monday, January 22, 2018ASSIGNED TO EXAMINER
Friday, October 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 16, 2017NEW APPLICATION ENTERED IN TRAM